Scientists hunt for clue in blood to explain why migraine drugs fail
NCT ID NCT07177885
Summary
This study aims to understand why some migraine patients do not get relief from common triptan medications. Researchers will compare blood levels of tryptophan, a dietary nutrient, and related substances in patients who respond well to triptans versus those who do not. The goal is to gather knowledge that could lead to better, more personalized migraine treatments in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Clermont-Ferrand
RECRUITINGClermont-Ferrand, France
Contact
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.